UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High fat feeding unmasks variable insulin responses in male C57BL/6 mouse substrains

Journal of endocrinology, 2017-04, Vol.233 (1), p.53-64

2017

Volltextzugriff (PDF)

Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice

Diabetologia, 2014-09, Vol.57 (9), p.1884-1888

2014

Volltextzugriff (PDF)

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs

Scientific reports, 2024-10, Vol.14 (1), p.25689-14, Article 25689

2024

Volltextzugriff (PDF)

Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro

Diabetologia, 2020-11, Vol.63 (11), p.2385-2395

2020

Volltextzugriff (PDF)

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Diabetologia, 2019-07, Vol.62 (7), p.1113-1122

2019

Volltextzugriff (PDF)

SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice

Journal of endocrinology, 2021-02, Vol.248 (2), p.95-106

2021

Volltextzugriff (PDF)

Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.888867-888867

2022

Volltextzugriff (PDF)

The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner

Frontiers in endocrinology (Lausanne), 2024-07, Vol.15, p.1432928

2024

Volltextzugriff (PDF)

A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes

Journal of Diabetes Research, 2018-01, Vol.2018 (2018), p.1-11

2018

Volltextzugriff (PDF)

Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

Endocrinology (Philadelphia), 2016-09, Vol.157 (9), p.3462-3468

2016

Volltextzugriff (PDF)

Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide

Diabetes (New York, N.Y.), 2005-07, Vol.54 (7), p.2235-2244

2005

Volltextzugriff (PDF)

Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes

Diabetes (New York, N.Y.), 2006-12, Vol.55 (12), p.3529-3535

2006

Volltextzugriff (PDF)

Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat

Diabetes care, 2007-10, Vol.30 (10), p.2673-2678

2007

Volltextzugriff (PDF)

Neprilysin Inhibitors and Angiotensin(1-7) in COVID-19

The British journal of cardiology, 2020-10, Vol.27 (4), p.109-111

2020

Volltextzugriff (PDF)

Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?

Diabetes research and clinical practice, 2022-09, Vol.191, p.110054-110054, Article 110054

2022

Volltextzugriff (PDF)

Gut-specific Neprilysin Deletion Protects Against Fat-induced Insulin Secretory Dysfunction in Male Mice

Endocrinology (Philadelphia), 2024-07, Vol.165 (8)

2024

Volltextzugriff (PDF)

Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels

Diabetologia, 2017-04, Vol.60 (4), p.701-708

2017

Volltextzugriff (PDF)

Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice

Endocrinology (Philadelphia), 2023-03, Vol.164 (5), p.1

2023

Volltextzugriff (PDF)

Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2

Journal of molecular endocrinology, 2022-08, Vol.69 (2), p.R63-R79

2022

Volltextzugriff (PDF)

Identification of the Amyloid-Degrading Enzyme Neprilysin in Mouse Islets and Potential Role in Islet Amyloidogenesis

Diabetes (New York, N.Y.), 2007-02, Vol.56 (2), p.304-310

2007

Volltextzugriff (PDF)

1546-P: Gut-Specific Neprilysin Deletion Increases Insulin Secretion in High-Fat–Fed Mice

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

292-LB: Cholesterol Accumulation in Islets Exacerbates Insulin Secretory Defects in a Model of Mild ß-Cell Dysfunction

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

The [beta] Cell in Diabetes: Integrating Biomarkers With Functional Measures

Endocrine reviews, 2021-10, Vol.42 (5), p.528

2021

Volltextzugriff (PDF)

Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice

The journal of histochemistry and cytochemistry, 2018-07, Vol.66 (7), p.523-530

2018

Volltextzugriff (PDF)

Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice

Peptides (New York, N.Y. : 1980), 2023-10, Vol.168, p.171076-171076, Article 171076

2023

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(78)
Webseiten
(14)

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Diabetes
(38)
Animals
(37)
Mice
(35)
Endocrinology & Metabolism
(32)
Human Health Sciences
(30)
Sciences De La Santé Humaine
(30)
Endocrinologie, Métabolisme & Nutrition
(29)
Endocrinology, Metabolism & Nutrition
(29)
Insulin Secretion
(29)
Male
(28)
Insulin
(26)
Diabetes Mellitus
(22)
Humans
(22)
Mice, Inbred C57bl
(20)
Glucose
(19)
Beta Cells
(18)
Insulin - Metabolism
(17)
Mice, Transgenic
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High fat feeding unmasks variable insulin responses in male C57BL/6 mouse substrains

Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs

Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice

Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice

The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner

A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes

Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide

Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes

Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat

Neprilysin Inhibitors and Angiotensin(1-7) in COVID-19

Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?

Gut-specific Neprilysin Deletion Protects Against Fat-induced Insulin Secretory Dysfunction in Male Mice

Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels

Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice

Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2

Identification of the Amyloid-Degrading Enzyme Neprilysin in Mouse Islets and Potential Role in Islet Amyloidogenesis

1546-P: Gut-Specific Neprilysin Deletion Increases Insulin Secretion in High-Fat–Fed Mice

292-LB: Cholesterol Accumulation in Islets Exacerbates Insulin Secretory Defects in a Model of Mild ß-Cell Dysfunction

The [beta] Cell in Diabetes: Integrating Biomarkers With Functional Measures

Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice

Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice

Suchergebnisse filtern